Precision Biosensor, Inc. (KOSDAQ:335810)

Market Cap	35.37B
Revenue (ttm)	19.59B
Net Income (ttm)	-7.64B
Shares Out	11.61M
EPS (ttm)	-659.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	36,827
Average Volume	34,322
Open	3,100.00
Previous Close	3,100.00
Day's Range	2,960.00 - 3,100.00
52-Week Range	2,430.00 - 5,700.00
Beta	0.67
RSI	51.22
Earnings Date	Aug 14, 2025

About MorphoSys AG

Precision Biosensor, Inc., an in-vitro diagnostics company, manufactures, distributes, and sells diagnostic reagents and analyzing devices in South Korea. The company offers cartridges for cardiac, infection, and brain, as well as colorectal, pregnancy, and vitamin D deficiency indications; and immunochromatographic analyzers. It also provides thermostat devices for activating the reagent reactions; and IQC analyzers. The company was founded in 2015 and is headquartered in Daejeon, South Korea.

• Industry: Measuring and Controlling Devices, not elsewhere classified
• Founded: 2015
• Employees: 102
• Stock Exchange: KOSDAQ
• Ticker Symbol: 335810

Financial Performance

In 2024, Precision Biosensor's revenue was 19.13 billion, a decrease of -6.16% compared to the previous year's 20.39 billion. Losses were -7.31 billion, 62.7% more than in 2023.